Found 31 matching trials
Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction
PHASE2Acute myocardial infarction (AMI) is myocardial necrosis caused by acute an...
Location
Shanghai Zhongshan Hospital
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
PHASE2This randomized, multicenter, double-blind, placebo-controlled, parallel-gr...
Location
University Alabama At Birmingham
A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants
PHASE1This is a Phase I, open-label, randomized, four-treatment period, four-sequ...
Location
Multiple Locations
PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
PHASE2The incidence of chest CT manifestations of lung injury after radiotherapy ...
Location
Fujian Medical University Union Hospital
Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis
PHASE2This study is to evaluate the efficacy and safety of an antifibrotic agent,...
Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).
PHASE3This study is a national, multicenter, interventional, non-randomized, non-...
Location
Regional State Budgetary Institution of Healthcare "Regional Cinilcal Hospital"; Pulmonology
Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients
PHASE1The primary purpose of this multi-center, double-blind, placebo-controlled,...
Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)
N/AThe purpose of the study was to assess the clinical outcome of patients wit...
Location
Praxis Dr. med. Mathias Rolke und Dr. med. Peter Rückert
The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects
PHASE1The Safety, Tolerability and Pharmacokinetic Study of idiopathic pulmonary ...
Location
Covance Clinical Research Unit, Inc.
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
PHASE2PSSc-001 (LOTUSS)
This study is a Phase 2, multinational, open-label, rand...
Location
Mayo Clinic, Scottsdale